Source:http://linkedlifedata.com/resource/pubmed/id/10735950
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-4-19
|
pubmed:abstractText |
The Systemic Lupus Activity Measure (SLAM) is a system proposed by rheumatologists to measure disease activity in their patients with systemic lupus erythematosus (LE). It involves scoring a group of clinical symptoms and laboratory findings, the maximum possible score being 84. In systemic LE, the mid-point is between 9 and 12. We applied SLAM to 176 patients with cutaneous LE. Ninety-seven had localized discoid LE (L-DLE), 59 had disseminated discoid LE (D-DLE) and 20 had subacute cutaneous LE (SCLE). Eighty-five patients had low activity disease (0-4 points), 72 mildly active disease (5-9 points), 15 moderately active disease (10-14 points) and only four had very active disease (>/= 15 points). The most frequent lesions in patients who scored more than 10 points were photosensitivity, cicatricial alopecia, Raynaud's phenomenon and oral ulcers. Fifty patients were followed up for more than 5 years (mean follow-up 9 years). Nine of these had an increased SLAM score. Seven had L-DLE, one D-DLE and one SCLE. Seven of the 50 patients had photosensitivity, five cicatricial alopecia, five non-cicatricial alopecia, two Raynaud's phenomenon and two oral ulcers. Three patients who started with L-DLE evolved to D-DLE. The SLAM system is useful in the monitoring of disease activity in patients with cutaneous LE. Over time, even L-DLE patients may develop active disease. Photosensitivity, alopecia, oral ulcers and Raynaud's phenomenon seem to herald a worse prognosis.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0007-0963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
142
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
457-60
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10735950-Acute Disease,
pubmed-meshheading:10735950-Case-Control Studies,
pubmed-meshheading:10735950-Female,
pubmed-meshheading:10735950-Follow-Up Studies,
pubmed-meshheading:10735950-Humans,
pubmed-meshheading:10735950-Lupus Erythematosus, Cutaneous,
pubmed-meshheading:10735950-Lupus Erythematosus, Discoid,
pubmed-meshheading:10735950-Male,
pubmed-meshheading:10735950-Prognosis,
pubmed-meshheading:10735950-Reproducibility of Results,
pubmed-meshheading:10735950-Retrospective Studies,
pubmed-meshheading:10735950-Sensitivity and Specificity,
pubmed-meshheading:10735950-Severity of Illness Index
|
pubmed:year |
2000
|
pubmed:articleTitle |
Measuring the activity of the disease in patients with cutaneous lupus erythematosus.
|
pubmed:affiliation |
Clinica Dermatologica del'Università, Viale Benedetto XV 7, 16132 Genoa, Italy. rebdermo@unige.it
|
pubmed:publicationType |
Journal Article
|